CClinicalTrials.gg
CompletedNCT07749144VMBT-EFUpdated Aug 6, 2026

Effects of Weekly Basketball Training Distribution on Executive Function in Adolescents

An interventional study of Weekday-Distributed Basketball Training and Weekend-Concentrated Basketball Training in Executive Function in Healthy Adolescents, Physical Fitness and Adolescent Development, sponsored by Xi'an Medical University. Completed at 1 site in China. Open to participants aged 13 Years to 16 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-06.

Sponsored by Xi'an Medical University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Mar 2026, registered Jul 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
13 Years to 16 Years
Sex
All
01

Study summary

his study examined whether different ways of distributing the same weekly amount of basketball training affect executive function in adolescents. A total of 120 adolescents were randomly assigned to one of three groups: weekday-distributed basketball training, weekend-concentrated basketball training, or a control group that continued its usual activities.

Participants in both basketball training groups completed 180 minutes of training per week for 8 weeks. The weekday-distributed group trained for 36 minutes per session, five days per week, whereas the weekend-concentrated group trained for 90 minutes per session, two days per week. Executive function was assessed before and after the intervention.

The study aimed to determine whether basketball training improves executive function compared with usual activities and whether distributing the same weekly training volume across weekdays produces different effects from concentrating the training on weekends.

02

Conditions studied

  • Executive Function in Healthy Adolescents
  • Physical Fitness
  • Adolescent Development
03

In context

Lead sponsor

Xi'an Medical University is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Aged 13 to 16 years at enrollment.
  • Enrolled in the participating local middle school.
  • Medically eligible to participate in moderate-to-vigorous physical exercise.
  • No systematic basketball or other sport-specific training during the 3 months before enrollment.
  • Normal or corrected-to-normal vision and able to complete the computerized cognitive tasks.
  • Available to participate in the 8-week intervention and complete all scheduled assessments.
  • Written informed consent provided by a parent or legal guardian and assent provided by the participant.

Exclusion criteria

Exclusion Criteria:

  • Any illness or musculoskeletal injury that could prevent safe participation in basketball training.
  • Current participation in another structured exercise, sport-specific training, or cognitive-training program.
  • Any visual, neurological, or other condition that could interfere with completion of the computerized cognitive tasks.
  • Medical advice or contraindications against participation in moderate-to-vigorous physical exercise.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
120 participants (actual)

Study arms

  • Experimental
    Weekday-Distributed Basketball Training

    Participants completed 180 minutes of basketball training per week for 8 weeks. The training was distributed across five weekday sessions, with each session lasting 36 minutes.

    Behavioral: Weekday-Distributed Basketball Training

  • Experimental
    Weekend-Concentrated Basketball Training

    Participants completed 180 minutes of basketball training per week for 8 weeks. The training was concentrated into two weekend sessions, with each session lasting 90 minutes.

    Radiation: Weekend-Concentrated Basketball Training

  • No intervention
    Usual Activity Control

    Participants maintained their usual daily activities and received no additional structured basketball training during the 8-week study period.

Interventions

  • BehavioralWeekday-Distributed Basketball Training

    Participants completed basketball training five days per week for 8 weeks. Each session lasted 36 minutes, resulting in a total weekly training volume of 180 minutes.

  • RadiationWeekend-Concentrated Basketball Training

    Participants completed basketball training two days per week for 8 weeks. Each session lasted 90 minutes, resulting in a total weekly training volume of 180 minutes.

06

What researchers measure

Primary outcomes

  1. Change From Baseline in Flanker Reaction-Time Interference Effect

    Inhibitory control was assessed using a computerized Flanker task at baseline and immediately after the intervention. The reaction-time interference effect was calculated as the mean reaction time for incongruent trials minus the mean reaction time for congruent trials and was expressed in milliseconds. Change from baseline was calculated as the post-intervention value minus the baseline value. Lower interference scores indicate better inhibitory control, and a negative change indicates improvement.

    Time frame: Baseline and immediately after the 8-week intervention

  2. Change From Baseline in 1-Back Task Accuracy

    Working memory was assessed using a computerized 1-back task at baseline and immediately after the intervention. Performance was measured as the percentage of correct responses, ranging from 0% to 100%. Change from baseline was calculated as the post-intervention accuracy minus the baseline accuracy. Higher accuracy scores indicate better working memory performance, and a positive change indicates improvement.

    Time frame: Baseline and immediately after the 8-week intervention

  3. Change From Baseline in More-Odd Shifting Task Switching Cost

    Cognitive flexibility was assessed using a computerized More-Odd Shifting task at baseline and immediately after the intervention. Switching cost was calculated as the mean reaction time for switch trials minus the mean reaction time for repeat trials and was expressed in milliseconds. Change from baseline was calculated as the post-intervention value minus the baseline value. Lower switching-cost values indicate better cognitive flexibility, and a negative change indicates improvement.

    Time frame: Baseline and immediately after the 8-week intervention

07

Study locations

1 site
  • Xi'an Medical University
    Xi'an, Shaanxi 710021, China
08

References and documents

Individual participant data

Plan to share: No — De-identified individual participant data will not be shared because the study involved minors and the consent materials did not include authorization for sharing individual-level data beyond the original research purpose. Aggregate study results will be reported in scientific publications.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07749144
Lead sponsor
Xi'an Medical University
Responsible party
Xiaodong Cheng (Dr., Xi'an Medical University) — Principal investigator
First posted
Aug 6, 2026
Start date
Mar 1, 2026
Primary completion
May 1, 2026
Completion
Jun 1, 2026
Last update
Aug 6, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion